Last reviewed · How we verify
Intra-articular corticosteroid injections (intra-articular-corticosteroid-injections)
Intra-articular corticosteroid injections, developed by Pfizer Inc., are used to treat various joint-related conditions. The mechanism involves reducing inflammation within the joint. Key indications include osteoarthritis of the knee and hip, rheumatoid arthritis, tendinitis, and bursitis. This treatment has a significant commercial presence, with $21.2B in revenue. Clinical differentiation lies in its targeted approach to joint inflammation. Commercial significance is evident in its widespread use. Pipeline developments are not specified.
At a glance
| Generic name | intra-articular-corticosteroid-injections |
|---|---|
| Sponsor | Pfizer |
| Drug class | Corticosteroid |
| Target | Glucocorticoid receptor |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Osteoarthritis of the knee
- Osteoarthritis of the hip
- Rheumatoid arthritis
- Tendinitis (e.g., Achilles, rotator cuff)
- Bursitis (e.g., olecranon, prepatellar)
- Synovitis (e.g., of the knee, elbow)
- Epicondylitis (e.g., tennis elbow)
- Trigger finger
- Gouty arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Polymyalgia rheumatica
- Frozen shoulder
- Tendinosis (e.g., patellar)
Common side effects
- Arthralgia
- Headache
- Viral upper respiratory tract infection
- Injection site pain
- Toothache
- Upper respiratory tract infection
- Joint swelling
- Spinal pain
- Pyrexia
- Bronchitis
- Abdominal Pain Upper
- Diarrhea
Drug interactions
- Aspirin
- Anticoagulants
- Antibiotics
- Antifungals
- Cyclosporine
- Methotrexate
- Nonsteroidal anti-inflammatory drugs (NSAIDs)
- Warfarin
- Live vaccines
- Typhoid vaccine
Key clinical trials
- OMT for Adhesive Capsulitis (PHASE4)
- Capsular Distension Versus Corticosteroid Injection in Adhesive Capsulitis (NA)
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Corticosteroid Meniscectomy Randomized Trial (PHASE4)
- Knee Injections for Obese Patients With Knee Arthritis (PHASE4)
- A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder (PHASE4)
- This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time (PHASE4)
- Ultrasound-Guided Intra-Articular vs Gluteal Intramuscular Corticosteroid Injection for Frozen Shoulder (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intra-articular corticosteroid injections CI brief — competitive landscape report
- Intra-articular corticosteroid injections updates RSS · CI watch RSS
- Pfizer portfolio CI